News Medical on MSN

ACCESS-AD: a new European initiative to accelerate timely and equitable AD diagnosis, treatment and care

Developed by a consortium of 30 public and private partners, ACCESS-AD (“Advancing Clinical Care and Equity through Scalable ...

Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in ...

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), today announced its participation as a key industry partner in ACCESS-AD, a major new European initiative designed to accelerate ...